tiprankstipranks
Trending News
More News >
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Income Statement

Compare
1,764 Followers

TransMedics Group Income Statement

Last quarter (Q4 2025), TransMedics Group's total revenue was $160.76M, an increase of 32.18% from the same quarter last year. In Q4, TransMedics Group's net income was $105.38M. See TransMedics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 605.49M$ 441.54M$ 241.62M$ 93.46M$ 30.26M
Gross Profit
$ 362.81M$ 262.08M$ 154.09M$ 65.27M$ 21.16M
Operating Expenses
$ 254.22M$ 224.59M$ 182.82M$ 96.71M$ 60.59M
Depreciation and Amortization
$ 27.18M$ 19.76M$ 8.18M$ 3.48M$ 1.82M
EBITDA
$ 148.49M$ 69.95M$ -7.70M$ -28.96M$ -38.49M
Operating Income
$ 108.58M$ 37.50M$ -28.73M$ -31.44M$ -39.43M
Other Income/Expenses
$ -1.06M$ -1.72M$ 2.06M$ -4.73M$ -4.75M
Pretax Income
$ 107.52M$ 35.78M$ -26.67M$ -36.16M$ -44.18M
Net Income
$ 190.29M$ 35.46M$ -25.03M$ -36.23M$ -44.22M
Per Share Metrics
Basic EPS
$ 5.60$ 1.07$ -0.77$ -1.23$ -1.60
Diluted EPS
$ 4.87$ 1.01$ -0.77$ -1.23$ -1.60
Weighted Average Shares Outstanding
33.99M 33.23M 32.52M 29.56M 27.62M
Weighted Average Shares Outstanding (Diluted)
40.54M 35.22M 32.52M 29.56M 27.62M
Currency in USD

TransMedics Group Earnings and Revenue History